Will West and Schott’s collaboration pave the way for more vendor-to-vendor partnerships?

Sitting Down With… Paul Peter Tak, President and CEO at Kintai Therapeutics.

How far along is the pharmaceutical industry in its journey with 3D cell culture technologies?

What measures can companies take to ensure the safety of their employees amid the COVID-19 outbreak?

We speak with Richard Bourne about his work on pharmaceutical processes.

A new analytical technique could help in the production of purer pharmaceuticals.

Using green light, a titanium catalyst could be a non-hazardous alternative to commonly used metal-based catalysts.

Secretome engineering eliminates unwanted proteins in CHO-based bioprocessing.

We’re moving towards a data-driven future of enhanced manufacturing. And we must lay the foundations today.

Sitting Down With… Frédéric Triebel, Co-Founder, Chief Scientific Officer, and Chief Medical Officer of Immutep, France.